Deal Intelligence Blog

Insights for Deal Professionals

Data-driven analysis backed by 1,400+ primary-sourced biopharma transactions. Licensing benchmarks, negotiation strategies, and market intelligence.

356 articles

All Buyer Intelligence Deal Analysis Market Trend Deal Trends How Much Comparison Industry Analysis Market Analysis Negotiation Strategy Deal Strategy

FeaturedIndustry Analysis

Partnership Termination Trends: $40B+ in Dissolved Deals and the Impact on Out-Licensing Strategy

Over $40B in biopharma partnership value was terminated in 2024 alone. We analyze the top terminations, the pattern of serial deal dissolutions, and how this trend is reshaping out-licensing strategy and deal structure negotiations.

April 7, 20269 min read

Read article

Benchmark Your Next Deal

Get data-driven deal terms for any therapeutic area, modality, and clinical phase. Powered by 1,400+ primary-sourced biopharma transactions.

Try Solidus